通过多奥米克集成推进非小细胞肺癌管理:基因组学,代谢学和放射学的见解.
Martina Pierri1, Giovanni Ciani2, Maria Chiara Brunese2
1Department of Pharmacy, University of Salerno, Via Giovanni Paolo II, 132, 84084 Fisciano, Italy.
Diagnostics (Basel, Switzerland)
|October 29, 2025
概括
像基因组学,代谢学和放射学这样的多组学技术为非小细胞肺癌 (NSCLC) 提供了新的见解. 整合这些方法有助于早期诊断,个性化治疗和改善肺癌患者的临床决策.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 代谢学 代谢学 代谢学
- 无线电学 (Radiomics) 是一种无线电学.
背景情况:
- 多omics集成正在彻底改变癌症管理.
- 基因组学,代谢学和放射学为瘤生物学,诊断和治疗提供了洞察力.
- 非小细胞肺癌 (NSCLC) 是这些先进技术的关键重点.
研究的目的:
- 为了提供一个全面的概述omics在NSCLC的方法.
- 突出基因组学,代谢学和放射学在肺癌中的应用.
- 探索整合这些技术的潜力,以改善患者的治疗结果.
主要方法:
- 审查当前的omics技术,包括基因组学,基于NMR的代谢学和放射学.
- 对这些方法在非小细胞肺癌 (NSCLC) 的应用进行分析.
- 探索基因组,代谢组和放射组数据的整合.
主要成果:
- 基因组学确定了驱动NSCLC的关键遗传改变及其对治疗的反应.
- 代谢学揭示了瘤负担,进展和预后的生物标志物.
- 放射学量化瘤异质性,并预测治疗反应的非侵入性.
结论:
- 整合基因组学,代谢学和放射学可以提高对NSCLC生物学的理解.
- 这些多omics方法可以导致非侵入性预测模型和个性化疗法.
- 组合使用omics技术改善了肺癌患者的临床决策,有助于早期诊断和治疗选择.
相关概念视频
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
02:02Genomics
39.6K
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
39.6K